- Photon-Counting CT in the Head and Neck: Current Applications and Future Prospects
This article reviews the current clinical application of PCD-CT in head and neck imaging, specifically the temporal bones, facial bones, and paranasal sinuses. PCD-CT offers improved spatial resolution, better iodine contrast-to-noise ratio, reduced artifact, and lower radiation dose.
- Comparison of a Whole-Brain Contrast-Enhanced 3D TSE T1WI versus Orbits Contrast-Enhanced 2D Coronal T1WI at 3T MRI for the Detection of Optic Nerve Enhancement in Patients with Acute Loss of Visual Acuity
This retrospective, single-center study of 1023 patients presenting with acute loss of vision compared orbits contrast-enhanced 2D coronal T1WI with a whole-brain contrast-enhanced 3D TSE T1WI at 3T for the detection of optic nerve enhancement. The latter (WBCE-3D T1WI) demonstrated higher sensitivity and specificity in diagnosing optic neuritis, particularly in cases involving the canalicular segments.
- Perspectives from the Inaugural “Spinal CSF Leak: Bridging the Gap” Conference: A Convergence of Clinical and Patient Expertise
The “Spinal CSF Leak: Bridging the Gap” Conference highlighted collective insights from a diverse cohort of clinicians, researchers, and patients. This manuscript discusses the clinical, diagnostic, and treatment challenges of spinal CSF leak, concluding that a collaborative, multidisciplinary care team needs to provide a standardized-yet-flexible diagnostic protocol to address the variability in clinical presentations and often-subtle radiographic findings.
- The Differentiation between Progressive Disease and Treatment-Induced Effects with Perfusion-Weighted Arterial Spin-Labeling in High-Grade Gliomas
In this retrospective, single-center cohort study, 141 patients (173 lesions) with a new or increasing contrast-enhancing lesion after radiotherapy with or without chemotherapy were assessed with ASL perfusion. Although ASL performed poorly in differentiating progressive disease from treatment-induced effects in high-grade gliomas within 6 months after radiation therapy, it showed fair performance after this period.